Search by Drug Name or NDC
NDC 00069-0344-10 Abrysvo Details
Abrysvo
Abrysvo is a KIT in the VACCINE category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .
MedlinePlus Drug Summary
Why get vaccinated? RSV vaccine can prevent disease caused by Respiratory Syncytial Virus (RSV). RSV disease refers to an infection of the respiratory tract caused by RSV. RSV is a common virus that causes mild, cold-like symptoms. However, in some patient populations, RSV disease can be more serious in infants and older adults. Those older adults at higher risk of worse outcomes from RSV disease include those with: chronic heart or lung diseases weakened immune systems nursing home or long term care facility residents RSV is usually spread through direct contact with the virus such as droplets from another person's cough or sneeze contacting your eyes, nose or mouth. It can also be spread by touching a surface that has a virus on it, such as a doorknob, and then touching your face before washing your hands. Mild symptoms of RSV disease typically resolve in a week or two and include the following: runny nose decrease in appetite coughing sneezing fever wheezing In individuals at high risk of poor outcomes as previously described, RSV may cause shortness of breath and low oxygen levels or may also worsen chronic heart or lung disease, leading to hospital stay and even potentially death.
Related Packages: 00069-0344-10Last Updated: 03/24/2024
MedLinePlus Full Drug Details: RSV (Respiratory Syncytial Virus) Vaccine
Product Information
NDC | 00069-0344 |
---|---|
Product ID | 0069-0344_bac19b46-1505-4177-aaf2-616264deae24 |
Associated GPIs | |
GCN Sequence Number | 084892 |
GCN Sequence Number Description | RSV vacc, preF A and preF B/PF VIAL 120MCG/0.5 INTRAMUSC |
HIC3 | W7B |
HIC3 Description | VIRAL/TUMORIGENIC VACCINES |
GCN | 54296 |
HICL Sequence Number | 048999 |
HICL Sequence Number Description | RESPIRATORY SYNCYTIAL VIRUS VACCINE, PREF A AND B/PF |
Brand/Generic | Brand |
Proprietary Name | Abrysvo |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Respiratory Syncytial Virus Vaccine |
Product Type | VACCINE |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA125769 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00069-0344-10 (00069034410)
NDC Package Code | 0069-0344-10 |
---|---|
Billing NDC | 00069034410 |
Package | 10 TRAY in 1 CARTON (0069-0344-10) / 1 KIT in 1 TRAY (0069-0344-21) * .69 mL in 1 SYRINGE, GLASS (0069-0250-01) * .5 mL in 1 VIAL, GLASS (0069-0207-01) |
Marketing Start Date | 2023-07-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |